# Produce-Rx
This cost-effectiveness analysis was built based on the Tufts Diabetes, Obesity, and Cardioascular disease Model to evaluate the health and economic impact and cost-effectiveness of a national produce prescription project. 
The model was populated with NHANES participants in 2013-2018 cycles aged 40-80 years with diabetes and food insecurity, n=757, representing 5.7 million US adults
The incremental changes in health and economic incidence CVD events (first CVD events and recurrent CVD events are reported seperately), life-years, quality-adjusted life-years, healthcare costs, productivity costs, policy costs (policy specific)
